Nanocrystal technology, drug delivery and clinical applications
Jens-Uwe A H Junghanns, Rainer H MüllerDepartment of Pharmaceutical Technology, Biotechnology and Quality Management, Free University of Berlin, Berlin, GermanyAbstract: Nanotechnology will affect our lives tremendously over the next decade in very different fields, including medicine a...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2008
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/6fc7dab7fee146e18b6f4d0da84f5e7c |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:6fc7dab7fee146e18b6f4d0da84f5e7c |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:6fc7dab7fee146e18b6f4d0da84f5e7c2021-12-02T01:35:40ZNanocrystal technology, drug delivery and clinical applications1176-91141178-2013https://doaj.org/article/6fc7dab7fee146e18b6f4d0da84f5e7c2008-10-01T00:00:00Zhttp://www.dovepress.com/nanocrystal-technology-drug-delivery-and-clinical-applications-a2427https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Jens-Uwe A H Junghanns, Rainer H MüllerDepartment of Pharmaceutical Technology, Biotechnology and Quality Management, Free University of Berlin, Berlin, GermanyAbstract: Nanotechnology will affect our lives tremendously over the next decade in very different fields, including medicine and pharmacy. Transfer of materials into the nanodimension changes their physical properties which were used in pharmaceutics to develop a new innovative formulation principle for poorly soluble drugs: the drug nanocrystals. The drug nanocrystals do not belong to the future; the first products are already on the market. The industrially relevant production technologies, pearl milling and high pressure homogenization, are reviewed. The physics behind the drug nanocrystals and changes of their physical properties are discussed. The marketed products are presented and the special physical effects of nanocrystals explained which are utilized in each market product. Examples of products in the development pipelines (clinical phases) are presented and the benefits for in vivo administration of drug nanocrystals are summarized in an overview.Keywords: drug nanocrystals, pearl milling, high pressure homogenization, nanocrystal, DissoCubes, Nanopure, bioavailability enhancement, saturation solubility, dissolution velocity Jens-Uwe A H Junghanns Rainer H MüllerDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2008, Iss Issue 3, Pp 295-309 (2008) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine (General) R5-920 |
| spellingShingle |
Medicine (General) R5-920 Jens-Uwe A H Junghanns Rainer H Müller Nanocrystal technology, drug delivery and clinical applications |
| description |
Jens-Uwe A H Junghanns, Rainer H MüllerDepartment of Pharmaceutical Technology, Biotechnology and Quality Management, Free University of Berlin, Berlin, GermanyAbstract: Nanotechnology will affect our lives tremendously over the next decade in very different fields, including medicine and pharmacy. Transfer of materials into the nanodimension changes their physical properties which were used in pharmaceutics to develop a new innovative formulation principle for poorly soluble drugs: the drug nanocrystals. The drug nanocrystals do not belong to the future; the first products are already on the market. The industrially relevant production technologies, pearl milling and high pressure homogenization, are reviewed. The physics behind the drug nanocrystals and changes of their physical properties are discussed. The marketed products are presented and the special physical effects of nanocrystals explained which are utilized in each market product. Examples of products in the development pipelines (clinical phases) are presented and the benefits for in vivo administration of drug nanocrystals are summarized in an overview.Keywords: drug nanocrystals, pearl milling, high pressure homogenization, nanocrystal, DissoCubes, Nanopure, bioavailability enhancement, saturation solubility, dissolution velocity |
| format |
article |
| author |
Jens-Uwe A H Junghanns Rainer H Müller |
| author_facet |
Jens-Uwe A H Junghanns Rainer H Müller |
| author_sort |
Jens-Uwe A H Junghanns Rainer H Müller |
| title |
Nanocrystal technology, drug delivery and clinical applications |
| title_short |
Nanocrystal technology, drug delivery and clinical applications |
| title_full |
Nanocrystal technology, drug delivery and clinical applications |
| title_fullStr |
Nanocrystal technology, drug delivery and clinical applications |
| title_full_unstemmed |
Nanocrystal technology, drug delivery and clinical applications |
| title_sort |
nanocrystal technology, drug delivery and clinical applications |
| publisher |
Dove Medical Press |
| publishDate |
2008 |
| url |
https://doaj.org/article/6fc7dab7fee146e18b6f4d0da84f5e7c |
| work_keys_str_mv |
AT jensuweahjunghannsrainerhmampuumlller nanocrystaltechnologydrugdeliveryandclinicalapplications |
| _version_ |
1718402965196242944 |